K Number
K242750
Device Name
Central Station
Date Cleared
2025-06-05

(266 days)

Product Code
Regulation Number
870.2300
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Central Station is a network device, intended to display, record and print monitored physiological data from Nihon Kohden bedside monitors, telemetry receiver and/or transmitters.

Central Station does not perform any data processing on the data received from the Nihon Kohden compatible devices. When Central Station is connected with the Nihon Kohden bedside monitors and telemetry receivers/transmitters the Central Station can:
• Admit and discharge patients on the Nihon Kohden network.
• Display and manage compatible devices' real-time patient clinical data, vital signs, alarms and waveforms.
• Review and trend data calculated by connected Nihon Kohden devices.
• Store and transfer historical clinical data for the connected systems.
• Print patient data.

Central Station is intended for use in professional medical facilities by trained medical personnel.

Device Description

Central Station is software only product that is installed on a Commercial Off the Shelf (COTS) Computer.

Central Station displays waveforms data and numerical data from a connected bedside monitor, vital sign telemeter, or multiple patient receiver unit on the screen.

Central Station is a network device, intended to provide remote patient monitoring to medical personnel. Central Station displays a list of measured values and a trend graph. Numerical data and various waveforms are color-coded for each parameter. Central Station also has the function of displaying an alarm.

Alarm indication in Central Station is displayed as a result of a judgment by the bedside monitor, vital sign telemeter, or multiple patient receiver units connected to the Central Station. Central Station itself does not have the function to perform alarm indication judgment.

AI/ML Overview

The provided document is a 510(k) clearance letter for the "Central Station" device. This type of document primarily focuses on establishing substantial equivalence to a legally marketed predicate device rather than detailing specific performance acceptance criteria and study results in the same way as a full clinical trial report or a detailed design validation report would.

The document states:

  • "Central Station does not perform any data processing on the data received from the Nihon Kohden compatible devices."
  • "Alarm indication in Central Station is displayed as a result of a judgment by the bedside monitor, vital sign telemeter, or multiple patient receiver units connected to the Central Station. Central Station itself does not have the function to perform alarm indication judgment."
  • "The results of the substantial equivalence assessment, taken together with non-clinical bench testing, software verification, and validation demonstrate that the Central station does not raise concerns regarding its safety and effectiveness compared to its predicate device and operates in accordance with claimed indications for use."

Given these statements, the "Central Station" device is essentially a display, recording, and communication hub. It does not perform diagnostic algorithms or make independent judgments that would typically necessitate the kinds of detailed performance metrics (like sensitivity, specificity, or reader agreement) that are usually established through extensive multi-reader, multi-case (MRMC) studies with expert ground truth. Its primary function is to accurately display and relay data processed by other Nihon Kohden devices.

Therefore, the "acceptance criteria" and "study that proves the device meets the acceptance criteria" for this specific device (Central Station) would primarily revolve around:

  • Software Verification and Validation (V&V): Ensuring the software correctly displays, records, and transmits data as designed, and that all features (admit/discharge, trend display, printing, network communication) function as intended without errors.
  • Non-Clinical Bench Testing: Confirming interoperability with compatible devices, accuracy of data display, alarm relay, and network functionality.
  • Cybersecurity Compliance: Meeting regulatory requirements for cybersecurity.

The document explicitly states that "The software documentation was prepared following the FDA's 'Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices' (released June 14, 2023), specifically for an Enhanced Documentation Level." and "Verification testing was conducted at the system integration level to confirm that the device software fulfills its requirements and that safety and security risk mitigations, where applicable, were effective. Additionally, system-level testing was carried out to show that the software addresses user needs. All unit, integration, and system-level tests successfully met the test protocols."

Based on the provided text, it is not possible to extract the specific quantitative performance metrics (like sensitivity, specificity, or effect sizes for human readers) that would be relevant for a device performing complex data processing or diagnostic functions. The document emphasizes substantial equivalence and basic functional verification, not advanced AI/diagnostic performance validation.

However, I can infer the spirit of typical acceptance criteria and how a device like this would be proven to meet them, guided by the information provided.


Inferred Acceptance Criteria and Device Performance for "Central Station"

Given the device's stated function (display, record, print, and relay data without processing it for diagnosis or alarm judgment), the acceptance criteria would focus on functional correctness, data integrity, interoperability, and system reliability, rather than diagnostic accuracy metrics.

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria CategorySpecific Acceptance Criteria (Inferred)Reported Device Performance (Inferred from document)
Functional Performance1. Data Display Accuracy: All physiological data (waveforms, numerics, alarms) received from connected compatible devices are accurately and synchronously displayed."Display and manage compatible devices' real-time patient clinical data, vital signs, alarms and waveforms." "Numeric data and various waveforms are color-coded for each parameter." Implied: Accuracy of display confirmed via functional tests against known inputs from connected devices.
2. Data Recording & Storage: Historical clinical data, trends, and events are accurately stored and retrievable for the specified durations/files."Store and transfer historical clinical data for the connected systems." Review history data storage (e.g., Trendgraph: 120 hours, Arrhythmia recall: 1,500 files, Event list: 10,000 files). Implied: Storage and retrieval validated against specified capacities and data integrity checks.
3. Printing Functionality: Patient data can be accurately printed, including specified parameters like patient info, waveforms, and trends."Print patient data." Ability to print various review windows (Trend, Full Disclosure, Arrhythmia Recall, etc.). Implied: Printing validated for completeness and accuracy of generated reports.
4. Patient Management: Functions for admitting, discharging, pausing, and transferring patients within the network operate correctly."Admit and discharge patients on the Nihon Kohden network." Support for Admit, Discharge, Pause, Transfer functions (within one CS, between CSs, manual/auto entry). Implied: Workflow and data handling for patient management validated.
5. Alarm Relay: Alarms generated by connected bedside monitors are accurately received and displayed/mimicked by Central Station."Alarm indication in Central Station is displayed as a result of a judgment by the bedside monitor... Central Station itself does not have the function to perform alarm indication judgment." Implied: Alarms from connected devices are correctly received and presented as per design.
Interoperability & Connectivity1. Compatible Device Connection: Successful and stable connection to all specified Nihon Kohden bedside monitors, telemetry receivers/transmitters.Compatible with NK Bedside Monitors (BSM: 1700, 3000, 6000, G9, G5, G7), Vital Signs Monitor (SVM-7200), NK Telemetry (GZ-120/130/140), Multiple Patient Receiver/Transmitters (ORG-9700/9100, ZS-940, ZM-520/521/530/531), Central Monitor (CNS-6201/6801/2101). Max 32 connections. Implied: Connectivity and data exchange verified through testing with all listed compatible devices.
2. Network Communication: Reliable communication via NET-9/LS-NET protocol within the Nihon Kohden network."Network: Yes (NK Network)." "Communication protocol: NET-9/LS-NET communication." Implied: Network communication validated for stability, data integrity, and compliance with protocol.
Software Quality & Reliability1. Software Functionality: All software features operate as per specifications without critical errors or crashes."Verification testing was conducted at the system integration level to confirm that the device software fulfills its requirements... All unit, integration, and system-level tests successfully met the test protocols." Implied: Comprehensive software V&V confirmed functional correctness and absence of defects.
2. Cybersecurity: Device adequately mitigates cybersecurity risks and complies with relevant guidance."Cybersecurity information has been provided in line with the FDA's 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions' guidance document, dated September 27, 2023." "Interoperability-related risk management activities are included in Cybersecurity Risk Management activities." Implied: Security testing confirmed adherence to cybersecurity standards.
Risk Management1. Safety & Effectiveness: Risks associated with interoperability, anticipated users, and foreseeable misuse are adequately addressed."The CENTRAL STATION has been designed and verified through a risk analysis that considers the risks associated with interoperability, the anticipated users, reasonably foreseeable misuse, and reasonably foreseeable combinations of events that can result in a hazardous situation." Implied: Risk analysis documented and mitigation verified, ensuring the device does not raise new safety/effectiveness concerns compared to the predicate.

2. Sample Size and Data Provenance

  • Test Set Sample Size: Not explicitly stated as a "sample size" in the context of patient data for diagnostic algorithms, because the device doesn't perform diagnostic processing. The "test set" for this device would be a collection of test cases covering all functional requirements, interoperability scenarios with different compatible devices, alarm conditions (relayed), data storage limits, network loads, and user interaction flows. The document mentions "system integration level" and "system-level testing" and that "all unit, integration, and system-level tests successfully met the test protocols." This implies a comprehensive set of non-clinical, bench-level tests.
  • Data Provenance: Not applicable in the sense of clinical patient data (e.g., from specific countries, retrospective/prospective studies), as the device does not process primary patient data for diagnosis. The data used for testing would be simulated, generated, or derived from compatible Nihon Kohden monitor outputs in a lab setting to verify the Central Station's display and communication functions.

3. Number of Experts and Qualifications for Ground Truth

  • Not Applicable in the traditional sense for diagnostic AI. The ground truth for this device's performance would be the expected output based on its functional specifications and the known inputs from the connected Nihon Kohden devices. For example, if a connected monitor transmits an HR of 70 bpm, the ground truth is that the Central Station must display 70 bpm. These "ground truths" are established by engineering design specifications, not human expert consensus on clinical findings.
  • Experts Involved: Software engineers, quality assurance engineers, subject matter experts on the physiological monitoring systems, and potentially clinical users for usability and workflow testing. Their qualifications would be in device design, software development, testing, and clinical application.

4. Adjudication Method for the Test Set

  • Not Applicable in the context of clinical interpretation adjudication (e.g., 2+1 radiologist consensus). Adjudication in this context would be internal to the software development and testing process:
    • Test Pass/Fail Criteria: Predetermined pass/fail criteria for each test case.
    • Bug/Defect Resolution: Issues found during testing are logged as bugs, investigated by engineers, and resolved, followed by retesting.
    • Verification Sign-off: Test leads or design engineers review test results and formally sign off on the successful completion of verification.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

  • No, not performed for this device. An MRMC study is relevant for AI systems that assist human readers in making diagnostic decisions (e.g., radiologists reading X-rays with AI assistance). The Central Station device does not perform any such diagnostic assistance; it merely displays data from other (likely already cleared) devices. Its function is analogous to a monitor or a remote display unit, not a diagnostic AI.

6. Standalone (Algorithm Only) Performance

  • Not Applicable. This device does not have a "standalone algorithm" that performs diagnostic or data processing functions independently. Its function is entirely dependent on receiving data from other compatible Nihon Kohden devices.

7. Type of Ground Truth Used

  • Functional Specifications and Truth from Connected Devices: The ground truth for this device is based on its functional design specifications (e.g., "display received data," "store data for X hours," "print Y parameters") and the verified output from the connected Nihon Kohden bedside monitors and telemetry systems. It's about data integrity and display accuracy, not clinical outcomes or pathology.

8. Sample Size for the Training Set

  • Not Applicable. This device is described as "software only product" that "does not perform any data processing on the data received," and "Central Station itself does not have the function to perform alarm indication judgment." This strongly implies it is a rule-based or deterministic system, not a machine learning/AI system that requires a "training set" in the common sense (i.e., for learning patterns from data for prediction or classification). Therefore, there is no training set.

9. How the Ground Truth for the Training Set Was Established

  • Not Applicable. As there is no training set for an AI algorithm, there is no corresponding ground truth establishment process for a training set.

FDA 510(k) Clearance Letter - Central Station

Page 1

U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov

Doc ID # 04017.07.05

June 5, 2025

Nihon Kohden Digital Health Solutions, LLC
Arthur Webb
Director Software Quality
14 Bunsen
Irvine, California 92618

Re: K242750
Trade/Device Name: Central Station
Regulation Number: 21 CFR 870.2300
Regulation Name: Cardiac Monitor (Including Cardiotachometer And Rate Alarm)
Regulatory Class: Class II
Product Code: MSX, MHX, DRQ, MWI
Dated: May 2, 2025
Received: May 2, 2025

Dear Arthur Webb:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"

Page 2

K242750 - Arthur Webb Page 2

(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Page 3

K242750 - Arthur Webb Page 3

Sincerely,

Jennifer W. Shih -S

Jennifer Kozen
Assistant Director
Division of Cardiac Electrophysiology, Diagnostics,
and Monitoring Devices
Office of Cardiovascular Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

Page 4

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.

Indications for Use

Submission Number (if known)
K242750

Device Name
Central Station

Indications for Use (Describe)

Central Station is a network device, intended to display, record and print monitored physiological data from Nihon Kohden bedside monitors, telemetry receiver and/or transmitters.

Central Station does not perform any data processing on the data received from the Nihon Kohden compatible devices. When Central Station is connected with the Nihon Kohden bedside monitors and telemetry receivers/transmitters the Central Station can:

• Admit and discharge patients on the Nihon Kohden network.
• Display and manage compatible devices' real-time patient clinical data, vital signs, alarms and waveforms.
• Review and trend data calculated by connected Nihon Kohden devices.
• Store and transfer historical clinical data for the connected systems.
• Print patient data.

Central Station is intended for use in professional medical facilities by trained medical personnel.

Type of Use (Select one or both, as applicable)
☒ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov

An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.

Page 5

Page 1 of 9
Nihon Kohden Digital Health Solutions
Proprietary and Confidential

Traditional 510(k) – Central Station

K242750

510(k) Summary

This 510(k) summary of safety and effectiveness information is prepared in accordance 21 CFR §807.92.

SUBMITTER:

Nihon Kohden Digital Health Solutions, LLC
14 Bunsen, Irvine, CA 92618
Phone: (949) 474-9207

Preparation date: May 02, 2025

Primary Contact Person:

Arthur Webb
Director Software Quality
14 Bunsen, Irvine, CA 92618
Office Phone: (949)-445-8984
Mobile Phone: (949)-577-3849
Email: art_webb@nihonkohden.com

Secondary Contact Person:

Tejal Digambar Warange
Software Regulatory Affairs Specialist
14 Bunsen, Irvine, CA 92618
Mobile Phone: (857)-869-8214
Email: tejal_warange@nihonkohden.com

Device:

Device Name: Central Station
Device Common Name: System, Network and Communication, Physiological Monitor
Proprietary Name: Central Station
Marketing Names: Central Station
Regulation Medical Specialty: Cardiovascular
Classification Panel: Cardiovascular
Regulation Number: 870.2300
Device Class: II
Submission Type: 510(k)
Product Code: MSX
Subsequent Product Codes: DRQ, MHX, MWI
Premarket Review: Office of Cardiovascular Devices (OHT2), Cardiac Electrophysiology, Diagnostics, and Monitoring Devices (DHT2A)
Submission Basis: New Device
Previous 510(k) submissions: None
Submission Date: May 02, 2025

Predicate device:

Device Trade Name: CNS – 2101 Central Monitor
510(k) Number: K223567

Page 6

Page 2 of 9
Traditional 510(k) – Central Station
K242750

DEVICE DESCRIPTION

Central Station is software only product that is installed on a Commercial Off the Shelf (COTS) Computer.

Central Station displays waveforms data and numerical data from a connected bedside monitor, vital sign telemeter, or multiple patient receiver unit on the screen.

Central Station is a network device, intended to provide remote patient monitoring to medical personnel. Central Station displays a list of measured values and a trend graph. Numerical data and various waveforms are color-coded for each parameter. Central Station also has the function of displaying an alarm.

Alarm indication in Central Station is displayed as a result of a judgment by the bedside monitor, vital sign telemeter, or multiple patient receiver units connected to the Central Station. Central Station itself does not have the function to perform alarm indication judgment.

INDICATIONS FOR USE/INTENDED USE

Central Station is a network device, intended to display, record and print monitored physiological data from Nihon Kohden bedside monitors, telemetry receiver and/or transmitters.

Central Station does not perform any data processing on the data received from the Nihon Kohden compatible devices. When Central Station is connected with the Nihon Kohden bedside monitors and telemetry receivers/transmitters the Central Station can:

• Admit and discharge patients on the Nihon Kohden network.
• Display and manage compatible devices' real-time patient clinical data, vital signs, alarms and waveforms.
• Review and trend data calculated by connected Nihon Kohden devices.
• Store and transfer historical clinical data for the connected systems.
• Print patient data.

Central Station is intended for use in professional medical facilities by trained medical personnel.

SUBMISSION SCOPE

Nihon Kohden Digital Health Solutions (NKDHS) is requesting market clearance for the Central Station. The Central Station communicates with other NK devices on the NK network (NET-9).

Comparison of Technological Characteristics with the Predicate Device

Central Station has the same intended use/ indication for use, and technological Characteristics, as the predicate CNS–2101 Central Monitor. Both the predicate as well as subject device intended to display, record, and print monitored physiological data from Nihon Kohden bedside monitors, telemetry receiver and/or transmitters.

Page 7

Page 3 of 9
Traditional 510(k) – Central Station
K242750

COMPARISON TABLE

The table below contains a detailed comparison of the Central Station to the Predicate Device (K223567).

CharacteristicsCentral Station (Proposed Device)CNS-2101 Central Monitor (Predicate Device: K223567) Info on predicateComparison
Regulation items
Classification PanelCardiovascularCardiovascularSame
Device NameSystem, Network And Communication, Physiological MonitorsSystem, Network And Communication, Physiological MonitorsSame
Regulatory ClassClass II (performance standards)Class II (performance standards)Same
Regulatory Number21CFR 870.2300- Cardiac monitor (including cardiotachometer and rate alarm)21CFR 870.2300- Cardiac monitor (including cardiotachometer and rate alarm)Same
Product CodePrimary Product Codes: MSX - System, network and communication, physiological monitorsSubsequent Product Codes:MHX- Monitor, physiological, patient (with arrhythmia detection or alarms)DRQ- Amplifier and signal conditioner, transducer signalMWI Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)Primary Product Codes: MSX - System, network and communication, physiological monitorsSubsequent Product Codes:MHX- Monitor, physiological, patient (with arrhythmia detection or alarms)DRQ- Amplifier and signal conditioner, transducer signalMWI Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)Both devices share the same MSX primary code and performance specifications. The subsequent (secondary) product codes are related to the type of the devices the CNS can connect to. The NK systems were cleared with the additional secondary codes.

Page 8

Page 4 of 9
Traditional 510(k) – Central Station
K242750

CharacteristicsCentral Station (Proposed Device)CNS-2101 Central Monitor (Predicate Device: K223567) Info on predicateComparison
Indications for UseCentral Station is a network device, intended to display, record and print monitored physiological data from Nihon Kohden bedside monitors, telemetry receiver and/or transmitters.Central Station does not perform any data processing on the data received from the Nihon Kohden compatible devices. When Central Station is connected with the Nihon Kohden bedside monitors and telemetry receivers/transmitters the Central Station can:• Admit and discharge patients on the Nihon Kohden network.• Display and manage compatible devices' real-time patient clinical data, vital signs, alarms and waveforms.• Review and trend data calculated by connected Nihon Kohden devices.• Store and transfer historical clinical data for the connected systems.• Print patient data.Central Station is intended for use in professional medical facilities by trained medical personnel.The CNS-2101 central monitor is a networked multipatient monitoring system, that is intended to display, record and print monitored physiological data from Nihon Kohden bedside monitors, telemetry receiver and/or transmitters.The CNS-2101 does not perform any data processing on the data received from the Nihon Kohden compatible devices. When the CNS-2101 is to connect with the Nihon Kohden bedside monitors and telemetry receivers/transmitters the CNS-2101 can:• Admit and discharge patients on the Nihon Kohden network.• Display and manage compatible devices' real-time patient clinical data.• Mimic the alarms of connected devices when a measured parameter falls outside a preset limits or when an arrhythmia is detected.• Review and trend data calculated by connected Nihon Kohden devices.• Store and transfer historical clinical data for the connected systems.• Print patient data.The CNS-2101 is intended for use in professional medical facilities by trained medical personnel.Same Intended use but the indications for uses has some minor editorial
Hardware
Display1,920× 1,080 resolution 23.8-inch color TFT type LCD1,920× 1,080 resolution 23.8-inch color TFT type LCDSame
Operation SystemMicrosoft Windows 10 IoT (Embedded)Microsoft Windows 10 IoT (Embedded)Same.
Storage media512GB (Solid State Drive)480 GB SSD (Solid State Drive)Substantial Equivalence.

Page 9

Page 5 of 9
Traditional 510(k) – Central Station
K242750

CharacteristicsCentral Station (Proposed Device)CNS-2101 Central Monitor (Predicate Device: K223567) Info on predicateComparison
Indications for UseCentral Station is a network device, intended to display, record and print monitored physiological data from Nihon Kohden bedside monitors, telemetry receiver and/or transmitters.Central Station does not perform any data processing on the data received from the Nihon Kohden compatible devices. When Central Station is connected with the Nihon Kohden bedside monitors and telemetry receivers/transmitters the Central Station can:• Admit and discharge patients on the Nihon Kohden network.• Display and manage compatible devices' real-time patient clinical data, vital signs, alarms and waveforms.• Review and trend data calculated by connected Nihon Kohden devices.• Store and transfer historical clinical data for the connected systems.• Print patient data.Central Station is intended for use in professional medical facilities by trained medical personnel.The CNS-2101 central monitor is a networked multipatient monitoring system, that is intended to display, record and print monitored physiological data from Nihon Kohden bedside monitors, telemetry receiver and/or transmitters.The CNS-2101 does not perform any data processing on the data received from the Nihon Kohden compatible devices. When the CNS-2101 is to connect with the Nihon Kohden bedside monitors and telemetry receivers/transmitters the CNS-2101 can:• Admit and discharge patients on the Nihon Kohden network.• Display and manage compatible devices' real-time patient clinical data.• Mimic the alarms of connected devices when a measured parameter falls outside a preset limits or when an arrhythmia is detected.• Review and trend data calculated by connected Nihon Kohden devices.• Store and transfer historical clinical data for the connected systems.• Print patient data.The CNS-2101 is intended for use in professional medical facilities by trained medical personnel.Same Intended use but the indications for uses has some minor editorial
Hardware
Display1,920× 1,080 resolution 23.8-inch color TFT type LCD1,920× 1,080 resolution 23.8-inch color TFT type LCDSame
Operation SystemMicrosoft Windows 10 IoT (Embedded)Microsoft Windows 10 IoT (Embedded)Same.
Storage media512GB (Solid State Drive)480 GB SSD (Solid State Drive)Substantial Equivalence.
AudioBuilt-in speakersBuilt-in speakersSame
Operation Methods
TouchscreenYesYesSame
KeyboardYesYesSame
MouseYesYesSame
Installation methodStand / Wall mountStand / Wall mountSame
Power sourceAC Power SupplyAC Power SupplySame
Power interruption supportNoYes- Internal battery (3-minute backup)The CNS-2101 has an internal battery. Central Station supports an external Uninterruptible power supply battery. The difference does not raise questions of safety and effectiveness of the subject device.
NetworkYesYes (NK Network)Same
Compatible monitoring systemsNK Bedside Monitors (MHX): BSM: 1700, 3000, 6000, G9, G5, G7Vital Signs Monitor (MWI): SVM-7200NK Telemetry (MHX/DRG): GZ-120/130/140Multiple Patient Receiver and Transmitters (DRG): ORG-9700/9100(DRT): ZS-940, ZM-520/521/530/531Central Monitor (MHX): CNS6201/6801/2101NK Bedside Monitors (MHX): BSM: 1700, 3000, 6000, G9, G5, G7Vital Signs Monitor (MWI): SVM-7200NK Telemetry (MHX/DRG): GZ-120/130/140Multiple Patient Receiver and Transmitters (DRG): ORG-9700/9100(DRT): ZS-940, ZM-520/521/530/531Central Monitor (MHX): CNS- 6201 and 6801Same The CNS communicates with other monitoring stems within the manufacturers product portfolio.
Extended DisplayYesYesSame
Max connections are supported for one Central StationUp to 32Up to 32Same
Communication protocol (and compatible monitors)NET-9/LS-NET communicationNET-9/LS-NET communicationSame - Both devices use a communication protocol to communicate between devices on the network.
Output to EMRYesYesSame
Serial Data Output capableYesYesSame
Display
Wave DisplayYesYesSame
Numeric DisplayYesYesSame

Page 10

Page 6 of 9
Traditional 510(k) – Central Station
K242750

CharacteristicsCentral Station (Proposed Device)CNS-2101 Central Monitor (Predicate Device: K223567) Info on predicateComparison
Patient Admit/Discharge
Patient Admit/Discharge/TransferFollowing functions are supported• Admit, Discharge, Pause, and Transfer functions• Patient transfer within one central station• Patient transfer between central stations• Entering patient information (Manual, Auto)Following functions are supported• Admit, Discharge, Pause, and Transfer functions• Patient transfer within one central station• Patient transfer between central stations• Entering patient information (Manual, Auto)Same
Review window
Review windows• Trend window• Tabular Trend window• Full Disclosure window• Expanded Waveform window• Arrhythmia Recall window• ST Recall window• Event List window• Alarm Events window• ECG 12 Lead Analysis window• Hemodynamics List window• SpO2 Trend window• Trend window• Tabular Trend window• Full Disclosure window• Expanded Waveform window• Arrhythmia Recall window• ST Recall window• Event List window• Alarm Events window• ECG 12 Lead Analysis window• Hemodynamics List window• SpO2 Trend windowSame - Both devices can connect and display monitored parameters. The viewable data points are similar on each of the monitoring system.
Review history• Trendgraph data: 120 hours• Tabular trend data: 120 hours• Full disclosure and expanded waveform data: 120 hours• Arrhythmia recall data: 1,500 files• Event list data: 10,000 files• Alarm events data: 120 files• ECG 12 lead analysis data: 200 files• ST recall data: 120 files• Hemodynamics list data: 256 files• SpO2 trendgraph data: 120 hours• Trendgraph data: 120 hours• Tabular trend data: 120 hours• Full disclosure and expanded waveform data: 120 hours• Arrhythmia recall data: 1,500 files• Event list data: 10,000 files• Alarm events data: 120 files• ECG 12 lead analysis data: 200 files• ST recall data: 120 files• Hemodynamics list data: 256 files• SpO2 trendgraph data: 120 hoursSame - Both devices provide review history data on the central monitor system each of the system can store data. The differences do not affect their substantial equivalence.
Alarm
Setting Alarm PrioritiesBedside Monitor: NoTelemetry system and transmitter: YesBedside Monitor: NoTelemetry system and transmitter: YesSame
Printing and Recording

Page 11

Page 7 of 9
Traditional 510(k) – Central Station
K242750

CharacteristicsCentral Station (Proposed Device)CNS-2101 Central Monitor (Predicate Device: K223567) Info on predicateComparison
PrintPatient information (Hospital Name, Bed name, Patient name)Recording start time or file creation date and timeRecording type (Multiple Waveform, Expanded Waveform, Trend, Tabular Trend, Full Disclosure, Arrhythmia Recall, ST Recall, Event List, Alarm Event, ECG 12 Lead Analysis, Hemodynamics List) and Review window parameters• Trend window• Tabular Trend window• Full Disclosure window• Expanded Waveform window• Arrhythmia Recall window• ST Recall window• Event List window• Alarm Events window• ECG 12 Lead Analysis window• Hemodynamics List window• SpO2 Trend windowPatient information (Hospital Name, Bed name, Patient name)Recording start time or file creation date and timeRecording type (Multiple Waveform, Expanded Waveform, Trend, Tabular Trend, Full Disclosure, Arrhythmia Recall, ST Recall, Event List, Alarm Event, ECG 12 Lead Analysis, Hemodynamics List) and Review window parameters• Trend window• Tabular Trend window• Full Disclosure window• Expanded Waveform window• Arrhythmia Recall window• ST Recall window• Event List window• Alarm Events window• ECG 12 Lead Analysis window• Hemodynamics List window• SpO2 Trend windowSame - Both devices are capable of printing to an external network printer.
RecordingNoPatient information (Hospital Name, Bed name, Patient name)Recording start time or file creation date and timeRecording type (Multiple Waveform, Expanded Waveform, Trend, Tabular Trend, Full Disclosure, Arrhythmia Recall, ST Recall, Event List, Alarm Event, ECG 12 Lead Analysis, Hemodynamics List)Recording duration, Recording speed (25 or 50 mm/s), Numeric data, Waveforms (up to 16 channels), Sensitivity, LeadWaveform PrintingCNS-2101 is capable of printing on a thermal printer when the parameters fall outside the limits.
ECG Features
ECG Functions DisplayYesYesSame
HR DisplayYesYes
ST Alarm Page settingsUpper Limit: OFF, −1.99 to 2.00 mVLower Limit: OFF, −2.00 to 1.99 mVUpper Limit: OFF, −1.99 to 2.00 mVLower Limit: OFF, −2.00 to 1.99 mV
ST segment analysis DisplayYesYes

Page 12

Page 8 of 9
Traditional 510(k) – Central Station
K242750

CharacteristicsCentral Station (Proposed Device)CNS-2101 Central Monitor (Predicate Device: K223567) Info on predicateComparison
Arrhythmia detection DisplayYesYes
Arrhythmia analysis SettingYesYes
QTc/QRSd displaySpot check and continuous When connected to BSM-1700, G5 and G7Spot check and continuous When connected to BSM-1700, G5 and G7
QRS detection DisplayYesYes
Pace pulse rejection (Display)YesYes

Summary of Nonclinical/Bench Studies

Software

The software documentation was prepared following the FDA's "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" (released June 14, 2023), specifically for an Enhanced Documentation Level. The rationale for choosing this documentation level is detailed in the Documentation Level document.

Verification testing was conducted at the system integration level to confirm that the device software fulfills its requirements and that safety and

Page 13

Page 9 of 9
Traditional 510(k) – Central Station
K242750

security risk mitigations, where applicable, were effective. Additionally, system-level testing was carried out to show that the software addresses user needs. All unit, integration, and system-level tests successfully met the test protocols.

Cybersecurity information has been provided in line with the FDA's "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions" guidance document, dated September 27, 2023.

The CENTRAL STATION has been designed and verified through a risk analysis that considers the risks associated with interoperability, the anticipated users, reasonably foreseeable misuse, and reasonably foreseeable combinations of events that can result in a hazardous situation. Our Interoperability-related risk management activities are included in Cybersecurity Risk Management activities.

Conclusion:

The results of the substantial equivalence assessment, taken together with non-clinical bench testing, software verification, and validation demonstrate that the Central station does not raise concerns regarding its safety and effectiveness compared to its predicate device and operates in accordance with claimed indications for use.

§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).

(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).